Literature DB >> 12393410

Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases.

Kent W Christopherson1, Antoinette F Hood, Jeffrey B Travers, Heather Ramsey, Robert A Hromas.   

Abstract

The signals that mediate T-cell infiltration during T-cell autoimmune diseases are poorly understood. The chemokine CCL21 (originally isolated by us and others as Exodus-2/6Ckine/SLC/TCA4) is highly potent and highly specific for stimulating T-cell migration. However, it is thought to be expressed only in secondary lymphoid organs, directing naive T cells to areas of antigen presentation. It is not thought to play a role in T-cell effector function during a normal immune response. In this study we tested the expression of T-cell chemokines and their receptors during T-cell autoimmune infiltrative skin diseases. By using immunohistology it was found that the expression of CCL21 but not CCL19 or 20 was highly induced in endothelial cells of T-cell autoimmune diseases. The receptor for CCL21, CCR7, was also found to be highly expressed on the infiltrating T cells, most of which expressed the memory CD45Ro phenotype. These data imply that the usual loss of CCL21 responsiveness in the normal development of memory T-cell effector function does not hold for autoimmune skin diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393410     DOI: 10.1182/blood-2002-05-1586

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues.

Authors:  Vanja Sisirak; Nelly Vey; Béatrice Vanbervliet; Thomas Duhen; Isabelle Puisieux; Bernhard Homey; Edward P Bowman; Giorgio Trinchieri; Bertrand Dubois; Dominique Kaiserlian; Sergio A Lira; Alain Puisieux; Jean-Yves Blay; Christophe Caux; Nathalie Bendriss-Vermare
Journal:  Blood       Date:  2011-09-21       Impact factor: 22.113

2.  Increased number of mature dendritic cells in Crohn's disease: evidence for a chemokine mediated retention mechanism.

Authors:  P Middel; D Raddatz; B Gunawan; F Haller; H-J Radzun
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

3.  Chemokines and their receptors in human renal allotransplantation.

Authors:  Denise J Lo; Tim A Weaver; David E Kleiner; Roslyn B Mannon; Lynn M Jacobson; Bryan N Becker; S John Swanson; Douglas A Hale; Allan D Kirk
Journal:  Transplantation       Date:  2011-01-15       Impact factor: 4.939

4.  Induction of High Endothelial Venule-like Vessels in Oral and Cutaneous Lichen Planus: A Comparative Study.

Authors:  Hisato Yoshida; Yoshiaki Imamura; Hitoshi Yoshimura; Motohiro Kobayashi
Journal:  J Histochem Cytochem       Date:  2020-05       Impact factor: 2.479

Review 5.  Hematopoietic stem and progenitor cell trafficking.

Authors:  Irina B Mazo; Steffen Massberg; Ulrich H von Andrian
Journal:  Trends Immunol       Date:  2011-07-29       Impact factor: 16.687

6.  Trafficking pathways and characterization of CD4 and CD8 cells recruited to the skin of humans experimentally infected with Haemophilus ducreyi.

Authors:  Tricia L Humphreys; Lee Ann Baldridge; Steven D Billings; James J Campbell; Stanley M Spinola
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

7.  Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation.

Authors:  B Fevang; A Yndestad; J K Damås; B Halvorsen; A M Holm; K Beiske; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2009-08-12       Impact factor: 4.330

8.  A humanized monoclonal antibody against the endothelial chemokine CCL21 for the diagnosis and treatment of inflammatory bowel disease.

Authors:  Maegan L Capitano; Aruna Jaiswal; Hal E Broxmeyer; Yilianys Pride; Sarah Glover; Fatemah G Amlashi; Austin Kirby; Gayathri Srinivasan; Elizabeth A Williamson; Daniel Mais; Robert Hromas
Journal:  PLoS One       Date:  2021-07-01       Impact factor: 3.752

9.  The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one of the factors involved in pathogenesis of atopic dermatitis.

Authors:  Joanna Narbutt; Aleksandra Lesiak; Anna Sysa-Jedrzeiowska; Marcin Zakrzewski; Jarosław Bogaczewicz; Iwona Stelmach; Piotr Kuna
Journal:  Mediators Inflamm       Date:  2009-07-22       Impact factor: 4.711

10.  Induction and effector phase of allergic lung inflammation is independent of CCL21/CCL19 and LT-beta.

Authors:  Corinne Ploix; Riaz I Zuberi; Fu-Tong Liu; Monica J Carson; David D Lo
Journal:  Int J Med Sci       Date:  2009-03-10       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.